mitomycin has been researched along with docetaxel anhydrous in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (10.81) | 18.2507 |
| 2000's | 18 (48.65) | 29.6817 |
| 2010's | 13 (35.14) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Saijo, N | 1 |
| Crown, J; Nabholtz, JM | 1 |
| Crown, J | 1 |
| Goto, K; Hojo, F; Hosomi, Y; Kakinuma, R; Kodama, K; Matsumoto, T; Mito, K; Moriyama, E; Niho, S; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Tanaka, K; Uramoto, H | 1 |
| Sandler, A | 1 |
| Kubota, T | 1 |
| Aoki, H; Fukai, S; Hashimoto, K; Hayashihara, K; Ishida, T; Kuwahara, K; Minegishi, Y; Nemoto, E; Okano, T; Saito, T; Watanabe, K; Watanabe, S; Yanai, N | 1 |
| Kaneko, M; Oguchi, S; Saida, T; Uhara, H | 1 |
| Fujimura, T; Fushida, S; Kinami, S; Miwa, K; Miyamoto, K; Nao, F; Ninomiya, I; Nishimura, G; Ohta, T; Yokogawa, K | 1 |
| Du, CW; Li, DR; Lin, W; Lin, Y; Lin, YC; Wu, MY | 1 |
| Emi, M; Inoue, H; Kim, R; Tanabe, K; Toge, T; Uchida, Y | 1 |
| Hirai, I; Kawago, M; Kokawa, Y; Nishida, M; Okamura, Y; Oura, S; Sakurai, T; Sasaki, R; Tanino, H; Yoshimasu, T; Yuzaki, M | 1 |
| Iishi, H; Narahara, H; Sugimoto, N; Tatsuta, M | 1 |
| Bonetto, E; Di Carlo, V; Nicoletti, R; Panucci, MG; Passoni, P; Reni, M; Ronzoni, M; Staudacher, C; Villa, E; Zerbi, A | 1 |
| Dai, DJ; Lu, CD; Meng, H; Sun, YL; Tanigawa, N | 1 |
| Akiyama, T; Hirabayashi, Y; Hirai, T; Ikeda, M; Iki, K; Kubozoe, T; Matsumoto, H; Sadahira, Y; Tsunoda, T; Urakami, A; Yamamura, M; Yamashita, K | 1 |
| Baba, H; Beppu, T; Okabe, K; Sano, O; Yamanaka, T | 1 |
| Belda, C; Casado, E; Castro, J; Feliu, J; Galán, A; Gonzalez-Barón, M; Lomas, M; Madroñal, C; Martín, G; Rodriguez-Jaráiz, A; Sundlov, A | 1 |
| Anderson, H; Ashcroft, L; Baka, S; Booton, R; Dark, G; Dunlop, D; Laurence, V; Lorigan, P; Nicolson, M; O'Brien, M; O'Byrne, K; Snee, M; Thatcher, N | 1 |
| Agostana, B; Aitini, E; Ardizzoia, A; Ardizzoni, A; Bajetta, E; Bochicchio, AM; Bordonaro, R; Botta, M; Buzzoni, R; Cicero, G; Comella, G; Di Bartolomeo, M; Duro, M; Fagnani, D; Ferrario, E; Gevorgyan, A; Katia, D; Kildani, B; Mantovani, G; Mariani, L; Marini, G; Massidda, B; Mozzana, R; Oliani, C; Palazzo, S; Pinotti, G; Reguzzoni, G; Schieppati, G; Villa, E; Zilembo, N | 1 |
| Ashcroft, L; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T | 1 |
| Ernst, T; Gnad-Vogt, U; Hochhaus, A; Hofheinz, RD; Kripp, M; Lukan, N; Merx, K; Schultheis, B | 1 |
| Goto, K; Kim, YH; Kubota, K; Nagano, T; Naito, Y; Niho, S; Nishiwaki, Y; Ohmatsu, H; Saijo, N; Yoh, K | 1 |
| Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES | 1 |
| Ernst, T; Hochhaus, A; Hofheinz, RD; Hofmann, WK; Kripp, M; Kruth, J; Lukan, N; Merx, K; Nissen, J | 1 |
| Harita, S; Hiraki, A; Hiraki, S; Hotta, K; Kamei, H; Kanazawa, S; Kiura, K; Matsuo, K; Nogami, N; Segawa, Y; Shibayama, T; Sugimoto, K; Tabata, M; Takata, I; Takemoto, M; Takigawa, N; Tanimoto, M; Ueoka, H; Watanabe, Y; Yonei, T | 1 |
| Chade, DC; Dalbagni, G; Karakiewicz, PI; Scherr, DS; Shariat, SF | 1 |
| Gemba, K; Horita, N; Hotta, K; Kanazawa, S; Kiura, K; Matsuo, K; Moritaka, T; Nagata, T; Okimoto, N; Segawa, Y; Shinkai, T; Tabata, M; Takeda, H; Takemoto, M; Takigawa, N; Tamaoki, A; Tanimoto, M; Tokuda, Y; Ueoka, H; Watanabe, K | 1 |
| Barlow, LJ; Benson, MC | 1 |
| Burgazli, KM; Erdogan, A; Ertan, AK; Kavukcu, E; Mericliler, M | 1 |
| Ozdemir, O; Ozdemir, P; Ozhan, MH; Uluer, H; Veral, A | 1 |
| Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yonemura, Y; Zhang, Q | 1 |
| Chung, JI; Hwang, H; Kim, TS; Noh, GH | 1 |
| Ángeles-Bueno, WG; Díaz-Sifuentes, JM; Mendoza-Medina, DF; Mendoza-Sánchez, F; Montes-López, GA; Pérez-Landeros, JE | 1 |
| Chen, LF; Ji, ZH; Li, XB; Li, Y; Lin, YL; Ma, R; Yan, FC; Yang, ZR; Zhang, J | 1 |
| Goebel, S; Hoelzer, D; Leovsky, C; Meyer, FB; Spangel, SB; Thierbach, R | 1 |
10 review(s) available for mitomycin and docetaxel anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
Phase III randomized trials of docetaxel in patients with metastatic breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase III as Topic; Docetaxel; Humans; Mitomycin; Neoplasm Metastasis; Paclitaxel; Randomized Controlled Trials as Topic; Salvage Therapy; Taxoids; Vinblastine | 1999 |
Chemotherapy in metastatic non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Mitomycin; Paclitaxel; Taxoids; Tirapazamine; Triazines; Vinblastine; Vinorelbine | 2000 |
[Recent advance in gastric cancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Mitomycin; Paclitaxel; Prognosis; RNA, Messenger; Stomach Neoplasms; Taxoids; Thymidylate Synthase | 2000 |
[CPT-11 combined chemotherapy for metastatic gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Mitomycin; Oxonic Acid; Pyridines; Stomach Neoplasms; Taxoids; Tegafur | 2004 |
Update on intravesical agents for non-muscle-invasive bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Combined Modality Therapy; Cystectomy; Docetaxel; Humans; Mitomycin; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms | 2010 |
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Doxorubicin; Gemcitabine; Humans; Mitomycin; Paclitaxel; Taxoids; Thiotepa; Treatment Failure; Urinary Bladder Neoplasms | 2013 |
Discovery of asymptomatic Krukenberg tumors diagnosed during caesarean section: therapy with hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asymptomatic Diseases; Bevacizumab; Cesarean Section; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Humans; Hyperthermia, Induced; Incidental Findings; Infusions, Parenteral; Krukenberg Tumor; Mitomycin; Ovarian Neoplasms; Pregnancy; Taxoids | 2013 |
Use of synthetic stomata in abdominal carcinomatosis. Case report and literature review.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; Argon Plasma Coagulation; Bevacizumab; Carboplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Doxorubicin; Drainage; Fatal Outcome; Female; Humans; Hyperthermia, Induced; Intestinal Neoplasms; Intestinal Perforation; Mitomycin; Ovarian Neoplasms; Polyethylene Glycols; Surgical Stomas | 2019 |
13 trial(s) available for mitomycin and docetaxel anhydrous
| Article | Year |
|---|---|
Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary results.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Humans; Middle Aged; Mitomycin; Neoplasm Metastasis; Paclitaxel; Survival Analysis; Taxoids; Vinblastine | 1998 |
Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neutropenia; Paclitaxel; Taxoids | 1999 |
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Outcome | 2002 |
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Docetaxel; Female; Humans; Irinotecan; Male; Maximum Tolerated Dose; Middle Aged; Mitomycin; Pancreatic Neoplasms; Salvage Therapy; Taxoids; Treatment Outcome | 2004 |
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Taxoids; Treatment Outcome | 2006 |
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Quality of Life; Survival Analysis; Taxoids; Vinblastine | 2006 |
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neutropenia; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Thrombocytopenia; Treatment Outcome | 2006 |
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; DNA Repair; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Neoplasms, Squamous Cell; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Treatment Outcome | 2007 |
Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Mitomycin; Nausea; Neoplasms; Skin Diseases; Taxoids; Treatment Outcome; Vomiting | 2007 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids | 2010 |
Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Capecitabine; Deoxycytidine; Diarrhea; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Leukopenia; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Taxoids; Treatment Outcome | 2010 |
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Taxoids; Vindesine | 2010 |
Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Japan; Lung Neoplasms; Male; Mitomycin; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine | 2011 |
14 other study(ies) available for mitomycin and docetaxel anhydrous
| Article | Year |
|---|---|
[Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Failure; Vindesine | 2000 |
Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paclitaxel; Paget Disease, Extramammary; Radiography; Scrotum; Skin Neoplasms; Taxoids; Vincristine | 2002 |
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Vindesine | 2002 |
Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Mitomycin; Oligonucleotides; Oligonucleotides, Antisense; Paclitaxel; Prognosis; Proto-Oncogene Proteins c-bcl-2; Receptor, ErbB-2; Signal Transduction; Taxoids; Time Factors | 2003 |
[Histoculture drug response assay for solitary fibrous tumor--a case report].
Topics: Antineoplastic Agents; Cisplatin; Deoxycytidine; Diaphragm; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Mitomycin; Muscle Neoplasms; Neoplasms, Fibrous Tissue; Taxoids | 2004 |
[Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Middle Aged; Mitomycin; Neoplasm Proteins; RNA, Messenger; Stomach Neoplasms; Survivin; Taxoids | 2004 |
In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Camptothecin; Cisplatin; Colorectal Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; In Vitro Techniques; Irinotecan; Leucovorin; Male; Middle Aged; Mitomycin; Taxoids | 2005 |
[A case of advanced gastric cancer with liver and lung metastases markedly responded to TS-1-based sequential chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Oxonic Acid; Paclitaxel; Pyridines; Remission Induction; Taxoids; Tegafur | 2005 |
Re-challenge chemotherapy for relapsed non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Child; Cisplatin; Docetaxel; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2010 |
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Ifosfamide; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids | 2013 |
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; China; Cisplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Female; Humans; Hyperthermia, Induced; Kaplan-Meier Estimate; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Taxoids | 2016 |
Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Docetaxel; Epirubicin; Gemcitabine; Humans; Mitomycin; Urinary Bladder Neoplasms | 2017 |
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Loss, Surgical; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Erythrocyte Transfusion; Female; Humans; Hyperthermia, Induced; Intestinal Fistula; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Postoperative Complications; Postoperative Hemorrhage; Pseudomyxoma Peritonei; Retrospective Studies; Risk Factors; Young Adult | 2020 |
Metformin alters therapeutic effects in the BALB/c tumor therapy model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; BALB 3T3 Cells; Carcinogens; Cell Survival; Cell Transformation, Neoplastic; Culture Media; Docetaxel; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Fluorouracil; Glucose; Humans; Metformin; Methylcholanthrene; Mice; Mitomycin; Neoplasms | 2021 |